PubRank
Search
About
W R McCabe
Author PubWeight™ 89.84
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients.
Am J Med
1980
4.45
2
Comparison of the antibacterial activity of rifampicin and other antibiotics.
Am J Med Sci
1968
3.03
3
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients.
Am J Med
1980
3.03
4
Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.
J Immunol
1972
2.89
5
Limitations of the usefulness of the Limulus assay for endotoxin.
N Engl J Med
1973
2.84
6
Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates.
J Infect Dis
1978
2.72
7
Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. The role of gastric colonization.
N Engl J Med
1987
2.64
8
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia.
N Engl J Med
1975
2.63
9
Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia.
N Engl J Med
1981
2.56
10
Type-specific and cross-reactive antibodies in gram-negative bacteremia.
N Engl J Med
1972
2.42
11
Extrapulmonary tuberculosis revisited: a review of experience at Boston City and other hospitals.
Medicine (Baltimore)
1984
2.28
12
Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex.
Am J Med
1987
2.04
13
Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation.
Am Rev Respir Dis
1986
2.04
14
Serum complement levels in bacteremia due to gram-negative organisms.
N Engl J Med
1973
1.70
15
The relation of K-antigen to virulence of Escherichia coli.
J Infect Dis
1975
1.64
16
Nosocomial infection and fatality in medical and surgical intensive care unit patients.
Arch Intern Med
1988
1.58
17
Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.
Infect Immun
1977
1.56
18
Nephrotoxicity associated with cephalothin administration.
Arch Intern Med
1975
1.40
19
Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.
Infect Immun
1977
1.39
20
An outbreak of type 1 pneumococcal pneumonia in a men's shelter.
JAMA
1980
1.38
21
Bacteremia due to Fusobacterium species.
Am J Med
1983
1.35
22
Pseudobacteremia traced to cross-contamination by an automated blood culture analyzer.
Infect Control
1984
1.33
23
Mycobacterial cervical lymphadenopathy. Relation of etiologic agents to age.
JAMA
1984
1.31
24
Immunization with rough mutants of Salmonella minnesota. IV. Protection by antisera to O and rough antigens against endotoxin.
J Infect Dis
1983
1.29
25
Common enterobacterial antigen. I. Isolation and purification from Salmonella typhose 0:901.
J Immunol
1973
1.28
26
"Abacterial" and bacterial pyelonephritis. Immunofluorescent localization of bacterial antigen.
N Engl J Med
1969
1.28
27
A large outbreak of infections caused by a strain of Staphylococcus aureus resistant of oxacillin and aminoglycosides.
Am J Med
1981
1.28
28
Meningitis caused by gram-negative bacilli.
Ann Intern Med
1980
1.27
29
Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus.
J Infect Dis
1983
1.24
30
Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli.
J Infect Dis
1976
1.24
31
M proteins of group G streptococci isolated from bacteremic human infections.
Infect Immun
1987
1.24
32
Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum.
Infect Immun
1987
1.20
33
Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols.
Am J Med
1984
1.14
34
Immunofluorescent demonstration of the common enterobacterial antigen.
Proc Soc Exp Biol Med
1966
1.12
35
Meningitis caused by Acinetobacter calcoaceticus var anitratus. A specific hazard in neurosurgical patients.
Arch Neurol
1981
1.11
36
Cross-reactive antigens: their potential for immunization-induced immunity to Gram-negative bacteria.
J Infect Dis
1977
1.07
37
Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literature.
Medicine (Baltimore)
1990
1.05
38
Immunization with rough mutants of Salmonella minnesota: initial studies in human subjects.
J Infect Dis
1988
1.04
39
Gram-negative bacteremia.
Adv Intern Med
1974
1.00
40
Common enterobacterial antigen. 3. Initial titers and antibody response in bacteremia caused by gram-negative bacilli.
Infect Immun
1973
0.93
41
Immunofluorescent localization of bacterial antigen in pyelonephritis. I. The use of antisera against the common enterobacterial antigen in experimental renal lesions.
J Lab Clin Med
1967
0.93
42
Endotoxin and bacteremia due to gram-negative organisms.
N Engl J Med
1970
0.91
43
Bacteremia caused by group G streptococci in parenteral drug abusers: epidemiological and clinical aspects.
J Infect Dis
1986
0.90
44
Contamination of mechanical ventilators with tubing changes every 24 or 48 hours.
N Engl J Med
1982
0.89
45
Bacterial interference induced in embryonated eggs by staphylococci.
J Clin Invest
1967
0.88
46
Common enterobacterial antigen. II. Effect of immunization on challenge with heterologous bacilli.
Infect Immun
1973
0.87
47
Antibiotics and endotoxic shock.
Bull N Y Acad Med
1975
0.84
48
Naloxone versus placebo in treatment of septic shock.
Lancet
1985
0.83
49
Methicillin-resistant Staphylococcus aureus bacteremia linked to intravenous drug abusers using a "shooting gallery".
Am J Med
1986
0.83
50
A randomized study comparing a transparent polyurethane dressing to a dry gauze dressing for peripheral intravenous catheter sites.
Infect Control
1985
0.83
51
Clinical use of combinations of antimicrobial agents.
Antimicrob Agents Chemother (Bethesda)
1967
0.82
52
Endotoxin-associated protein: a potent stimulus for human granulocytopoietic activity which may be accessory cell independent.
Infect Immun
1988
0.81
53
Interactions of rifampin and trimethoprim in vitro.
Rev Infect Dis
1982
0.81
54
Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation.
Infect Immun
1988
0.80
55
Randomized clinical trial of aztreonam and aminoglycoside antibiotics in the treatment of serious infections caused by gram-negative bacilli.
Antimicrob Agents Chemother
1989
0.80
56
The role of lipopolysaccharide of gram-negative bacilli in sensitivity and resistance to serum.
Prog Clin Biol Res
1988
0.80
57
Pathophysiology of bacteremia.
Am J Med
1983
0.79
58
Xanthogranulomatous pyelonephritis caused by methicillin-resistant Staphylococcus aureus.
Am J Med
1984
0.79
59
Gram-negative bacteremia.
Dis Mon
1973
0.79
60
Potential use of shared antigens for immunization against gram-negative bacillary infections.
Prog Clin Biol Res
1980
0.78
61
Studies of staphylococcal infections. II. The role of bacteriophage type, antibiotic resistance, coagulase, and other exotoxins in infections in embryonated eggs.
Yale J Biol Med
1966
0.78
62
Empiric therapy for bacterial meningitis.
Rev Infect Dis
1983
0.77
63
Ototoxicity of erythromycin.
Lancet
1978
0.77
64
Antibody to endotoxin in the treatment of gram-negative sepsis.
JAMA
1992
0.77
65
Humoral immunity to gram-negative bacillary infections in experimental animals and man.
Infection
1975
0.76
66
A model for bacterial clearance in the lung.
Surgery
1972
0.75
67
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteria.
Infection
1980
0.75
68
Naloxone in septic shock.
Lancet
1985
0.75
69
The correlation of in vitro tests with the outcome of antimicrobial therapy for otitis media.
Pediatr Ann
1984
0.75
70
Trichinosis. Report of a small outbreak with observations of thiabendazole therapy.
Arch Intern Med
1967
0.75
71
Letter: Incidence of gram-negative bacteremia.
N Engl J Med
1975
0.75
72
Immunoprophylaxis of gram-negative bacillary infections.
Annu Rev Med
1976
0.75
73
Role of the reticuloendothelial system in bacterial interference in embryonated eggs.
J Lab Clin Med
1968
0.75
74
University of California/Davis Interdepartmental Conference on gram-negative septicemia.
Rev Infect Dis
1991
0.75
75
Detection of bacterial antigen in bacterial and "abacterial" pyelonephritis.
Trans Assoc Am Physicians
1969
0.75
76
Gram-negative rod bacteremia in cancer patients. A review with emphasis on the antibody response.
Eur J Cancer
1975
0.75
77
A clinical study of moxalactam in the treatment of infections due to gram-negative bacilli.
Scand J Infect Dis
1984
0.75
78
Adult bacteremia caused by gram-negative bacilli.
Clin Obstet Gynecol
1979
0.75